Jamie Cesanek

The goal of the phase 2 trial is to study the safety and efficacy of ASP-1929, a photoimmunotherapy with fluorescence imaging, in patients with head and neck or skin cancer.

New research has demonstrated that treatment with Rozlytrek induced meaningful responses in patients with NTRK fusion-positive solid tumors and may also effectively treat brain metastases in those patients.

From NBC4 meteorologist Bob Nunnally’s break for cancer treatments to Mary J. Blige’s Super Bowl commercial encouraging others to undergo cancer screenings, here’s what’s happening in the cancer landscape this week.

A trial to examine BMF-219 in patients with relapsed or refractory acute leukemias has begun recruiting patients across multiple U.S. states.

In this episode of the “Cancer Horizons” podcast, the founder of Jack’s Caregiver Coalition, a nonprofit organization dedicated to supporting men throughout the caregiving experience, explores the layered sociological factors which can affect men in unique ways when they are supporting a loved one with cancer.

From an Olympic gold medal win for cancer survivor Max Parrot to Sofía Vergara’s candidness about her cancer journey, here’s what’s happening in the cancer landscape this week.

On this episode of the “Cancer Horizons” podcast, former NFL linebacker Chris Draft discusses his wife’s experience with cancer, which led to her untimely death, and describes why advocacy is so important in the cancer world, especially with Cancer Moonshot bringing disparities to the forefront.

A phase 3 trial evaluating the safety and efficacy of the BTK inhibitor LOXO-305 in patients with previously treated mantle cell lymphoma is now open to patients across more than a dozen states.

Results from the SIENDO trial examining the effects of Xpovio as a frontline maintenance therapy in patients with advanced or recurrent endometrial cancer highlighted a significant survival benefit.

A phase 2b clinical trial evaluating the efficacy and safety of an immunotherapy drug for patients with brain cancer has opened at Roswell Park Comprehensive Cancer Center in Buffalo, New York, with additional plans to be carried out at more than a dozen sites.

From the death of a former New York Mets player due to cancer, to a lawsuit against Tokyo Electric Power Company Holdings regarding cancer potentially caused by the 2011 Fukushima nuclear disaster, here’s what’s happening in the cancer landscape this week.

On this episode of the “Cancer Horizons” podcast, a cancer nurse explains how her son’s leukemia diagnosis transformed her work, her research and her outlook on life.

With newer treatments like Keytruda (pembrolizumab) approved for patients with cervical cancer, a younger patient population may be concerned about experiencing side effects that interrupt their lives — but if they occur, clinicians will be ready with a plan for management, says an expert from the Uniformed Services University of the Health Sciences.

A phase 1/2a clinical trial examining the effects of a treatment called LAVA-1207 for patients with metastatic prostate cancer has now begun.

Patient sensitivity to chemotherapy prior to surgery could determine if a patient with gastric cancer needs to receive chemo after surgery.

Patients who limit alcohol intake during their cancer treatment may experience several health benefits, according to physicians from Tampa Bay Radiation Oncology.

From the lung cancer death of “Seinfeld” actress Kathryn Kates to a patient with cancer who broke a rowing world record, here’s what’s happening in the cancer landscape this week.

All clinical trials investigating the combination of magrolimab and the chemotherapy Onureg have been paused due to unforeseen serious side effects experienced by patients with various blood cancers receiving the treatment.

In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.

A clinical trial to evaluate Descartes-25, a novel allogeneic RNA cell therapy, for multiple myeloma has officially treated its first patient and is now recruiting in certain locations.

From mental impacts such as “scanxiety” and post-traumatic stress disorder to difficulties returning to work/dating and long-term physical side effects like memory issues, several cancer survivors shared the hardest part about survivorship.

Patients with metastatic cutaneous squamous cell carcinoma achieved promising response rates after treatment with cosibelimab. If approved, drug developers are hoping to offer cosibelimab as a more affordable immunotherapy option for this patient population.

Treating patients with liver cancer initially with Lenvima instead of the standard of care was associated with a survival benefit, according to recent research.

From the death of comedian Louie Anderson after he was hospitalized for cancer treatment to former world No.1 tennis player Chris Evert’s ovarian cancer diagnosis, here’s what’s happening in the cancer landscape this week.

Researchers plan to enroll 60 patients in the first-in-human phase 1 clinical trial to assess the safety and preliminary clinical activity of an anti-CD39 monoclonal antibody to treat advanced solid tumors.

Recent study results showed that the use of a remote monitoring device worn on the upper arm may help patients with blood cancers seek assistance for serious complications while receiving intensive treatments.

In this episode of the “Cancer Horizons” podcast, a cervical cancer survivor and advocate explains how she navigated being given six to 24 months to live as a single mother of three children and no health insurance.

A new study to evaluate the accuracy of a blood test for detecting lung cancer in high-risk adults has enrolled its first participant with plans to enroll thousands more.

A booster dose of the COVID-19 mRNA vaccine may provide patients with cancer with a broader and stronger protection against COVID-19 variants like omicron, according to a cancer researcher at The Ohio State University Comprehensive Cancer Center.

The STELLAR-002 trial is currently underway to examine the combination of XL092, an experimental tyrosine kinase inhibitor, in combination with immuno-oncology therapies for patients with advanced solid tumors.